Akorn - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Akorn M&A Summary

Akorn has acquired 5 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 4 assets.

Akorn’s largest acquisition to date was in 2013, when it acquired Hi-Tech Pharmacal for $640M. It’s largest disclosed sale occurred in 2021, when it sold Akorn - Consumer Health Business to Prestige Consumer Healthcare for $230M. Akorn has acquired in 4 different US states. The Company’s most targeted sectors include life science (40%) and medical products (40%).

Akorn Ownership

Who owns Akorn?

Akorn is owned by Fresenius Kabi USA. It was acquired on April 24, 2017.

Akorn Business Overview

Where is Akorn headquartered?

Akorn is headquartered in Lake Forest, Illinois.

What is Akorn’s revenue?

Akorn disclosed revenue of 1,117M USD for 2016 and 985M USD for 2015.

How many employees does Akorn have?

Akorn has 1,972 employees.

What sector is Akorn in?

Akorn is a life science company.

When was Akorn founded?

Akorn was founded in 1971.

M&A Summary

  • M&A Total Activity9
    • M&A Buy Activity5
    • M&A Sell Activity4
  • Total Sectors Invested 3
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 8
  • M&A Advisors 6

Akorn, Inc.

1925 West Field Court, Suite 300,
Lake Forest, Illinois 60045
United States,
(847) 279-6100
www.akorn.com

Akorn, Inc. is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Akorn, Inc. was founded in 1971 and is based in Lake Forest, Illinois.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 5 - - - - - 5
vol $1.2B $1.2B
Sell (0.4/yr) # 2 - 1 1 - - 4
vol $120M $230M $350M
  9

Most Recent M&A

Company Date Value Type
Akorn - Ophthalmic Products 2022-03-09 - Divestiture
Lake Forest, Illinois
Akorn, Inc. - Consumer Health Business 2021-05-27 230M USD Divestiture
Lake Forest, Illinois
Aciex Therapeutics, Inc. 2014-10-24 120M USD Trade Sale
Boston, Massachusetts · www.aciexrx.com
Xopenex Inhalation Solution 2014-09-30 45M USD Divestiture
, United States
VersaPharm, Inc. 2014-08-12 440M USD Add-on Acquisition
Marietta, Georgia · www.versapharm.com
Akorn - 4 New Drug Applications 2014-04-17 - Divestiture
, United States
Hi-Tech Pharmacal Co., Inc. 2013-08-27 640M USD Add-on Acquisition
Amityville, New York
Advanced Vision Research, Inc. 2011-03-05 26M USD Add-on Acquisition
Woburn, Massachusetts
Aciex Therapeutics, Inc. 2007-09-01 - Add-on Acquisition
Boston, Massachusetts · www.aciexrx.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Hi-Tech Pharmacal Co., Inc. 2013-08-27 Akorn - 4 New Drug Applications 2014-04-17 1
Amityville, New York , United States

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (40%) 440M (38%) 2 (50%) 350M (100%)
Medical Products 2 (40%) 685M (60%) 2 (50%) -
Consumer Products 1 (20%) 26M (2%) - -
Total 5 $1.2B 4 $350M

By Geo

State/Country Buy Value Sell Value
United States 5 1.2B 4 350M
  Massachusetts 2 26M 1 120M
  Illinois - - 2 230M
  Georgia 1 440M - -
  New York 1 640M - -
Total 5 $1.2B 4 $350M

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
2
Greenhill & Co., Inc.
1
William Blair
1
Legal Deals
Kirkland & Ellis
2
Willkie Farr & Gallagher
2
Polsinelli PC
1

Deal Values

buy # Total
$100M to $1B 2 $1.1B
< $100M 2 $71M
TOTAL $1.2B
Largest Hi-Tech Pharmacal Co., Inc.
$640M (2013-08-27)
sell # Total
$100M to $1B 2 $350M
TOTAL $350M
Largest Akorn, Inc. - Consumer Health Business
$230M (2021-05-27)

M&A Connections

Deals
Acquired from
Investor(s)
20%
1 (20%)
Strategic(s)
20%
1 (20%)
Divested to
Strategic(s)
100%
4 (100%)

 Subscribe to unlock this and 203,076
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.